Drugs / DS3790a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07220616 | Jan 2026 → Nov 2030 expected | B-cell non-Hodgkin lymphoma | Daiichi Sankyo | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS3790a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07220616 ↗ |